Health Canada released a stakeholder update explaining that, as part of the 2025 federal budget and Comprehensive Expenditure Review, the department is modernizing its operations to focus on core priorities like reviewing prescription drugs and biologics. To reduce regulatory burden, Health Canada plans to amend rules for natural health products and non‑prescription drugs so that products meeting established standards will no longer require pre‑market authorization. This three‑year transition will involve major internal changes, but the department aims to avoid service disruptions during the process.
While Health Canada has introduced several initiatives to streamline processes and reduce administrative burden—such as the NHP Workload Management initiative—Cosmetics Alliance expects the departments to demonstrate that these efforts are effective and that they deliver meaningful, validated value to stakeholders.
Stakeholder Letter on Comprehensive Expenditure Review – EN/FR
